These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 31352449
1. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology. Ang PP, Tan GC, Karim N, Wong YP. Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449 [Abstract] [Full Text] [Related]
2. EZH2, a unique marker of malignancy in effusion cytology. Jiang H, Gupta R, Somma J. Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867 [Abstract] [Full Text] [Related]
3. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Su XY, Li GD, Liu WP, Xie B, Jiang YH. Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004 [Abstract] [Full Text] [Related]
4. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions. Hanley KZ, Facik MS, Bourne PA, Yang Q, Spaulding BO, Bonfiglio TA, Xu H. Cancer; 2008 Feb 25; 114(1):49-56. PubMed ID: 18098206 [Abstract] [Full Text] [Related]
5. The importance of EZH2 and MOC-31 expression in the differential diagnosis of benign and malignant effusions. Sadullahoglu C, Nart D, Veral A. Diagn Cytopathol; 2017 Feb 25; 45(2):118-124. PubMed ID: 28024110 [Abstract] [Full Text] [Related]
6. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjåmer A, Berner A. Virchows Arch; 1999 Jul 25; 435(1):43-9. PubMed ID: 10431845 [Abstract] [Full Text] [Related]
7. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions]. Li XJ, Pan QJ, Shen GH, Liu XY, Sun YT. Zhonghua Zhong Liu Za Zhi; 2005 Jul 25; 27(7):438-41. PubMed ID: 16188134 [Abstract] [Full Text] [Related]
9. Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology. Oda T, Ogata S, Kawaguchi S, Minabe S, Dokyu M, Takahashi H, Kumazawa F, Shimazaki H, Takano M, Hase K, Ozeki Y, Kanoh S, Nakanishi K. Diagn Cytopathol; 2016 Jun 25; 44(6):499-504. PubMed ID: 27015745 [Abstract] [Full Text] [Related]
10. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg B, Johansen P. Am J Surg Pathol; 2001 Nov 25; 25(11):1405-12. PubMed ID: 11684957 [Abstract] [Full Text] [Related]
11. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindán J. Cancer; 2001 Feb 25; 93(1):68-72. PubMed ID: 11241268 [Abstract] [Full Text] [Related]
13. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology. Chen L, Caldero SG, Gmitro S, Smith ML, De Petris G, Zarka MA. Cancer Cytopathol; 2014 Jan 25; 122(1):70-5. PubMed ID: 23983174 [Abstract] [Full Text] [Related]
17. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H. Diagn Cytopathol; 2005 Mar 25; 32(3):151-5. PubMed ID: 15690338 [Abstract] [Full Text] [Related]
18. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1. Bailey ME, Brown RW, Mody DR, Cagle P, Ramzy I. Acta Cytol; 1996 Mar 25; 40(6):1212-6. PubMed ID: 8960030 [Abstract] [Full Text] [Related]